Dr. Michniak-Kohn’s main research focus lies in the area of topical, transdermal and buccal drug delivery. Her group is involved in the design and testing of novel dermal penetration enhancer and retardant compounds, investigation of their mechanisms of action and transport through the skin layers, molecular and computational modeling of enhancers as well as optimization and testing of topical and transdermal formulations.
